Results 51 to 60 of about 1,531,874 (315)

Risk-of-bias ratings for epidemiological studies (n = 42).

open access: yes, 2022
Criteria ratings served as the basis for the assignment of individual studies to one out of 3 study quality categories (1st tier, 2nd tier, 3rd tier; see S1 Fig). Black frames indicate key risk-of-bias criteria.
Dagmar Dechent (3930344)   +5 more
core   +1 more source

Methodological Standards for Conducting High-Quality Systematic Reviews

open access: yesBiology
Systematic reviews are a cornerstone of evidence-based research, providing comprehensive summaries of existing studies to answer specific research questions.
Alessandro De Cassai   +3 more
doaj   +1 more source

Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments [PDF]

open access: yesResearch Synthesis Methods, 2020
Despite a major increase in the range and number of software offerings now available to help researchers produce evidence syntheses, there is currently no generic tool for producing figures to display and explore the risk‐of‐bias assessments that routinely take place as part of systematic review. However, tools such as the R programming environment and
Luke A. McGuinness, Julian P. T. Higgins
openaire   +4 more sources

Risk-of-bias assessment.

open access: yes, 2018
Risk-of-bias assessment.
Nicolas Bertholet (834628)   +29 more
core   +1 more source

Risk-of-bias ratings for experimental studies (n = 11).

open access: yes, 2022
Criteria ratings served as the basis for the assignment of individual studies to one out of 3 study quality categories (1st tier, 2nd tier, 3rd tier; see S1 Fig). Black frames indicate key risk-of-bias criteria.
Dagmar Dechent (3930344)   +5 more
core   +1 more source

Challenges, quality and risks of quantitative and qualitative research

open access: yesFogyatékosság és Társadalom
Research bias is a rarely discussed yet important issue in Hungarian academic literature. Even in respected journals, bias often jeopardises the publication of data that may not be generalisable or valid.
Zagyi Emese   +2 more
doaj   +1 more source

Reporting and risk of bias of prediction models based on machine learning methods in preterm birth: A systematic review

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2023
Introduction There was limited evidence on the quality of reporting and methodological quality of prediction models using machine learning methods in preterm birth.
Qiuyu Yang   +8 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Systematic reviews of antihypertensive drugs: A review of publication trends, characteristics, and quality

open access: yesThe Journal of Clinical Hypertension, 2021
This review presents publication trends, characteristics, and quality of systematic reviews (SRs) of randomized controlled trials (RCTs) of antihypertensive drugs (AHTDs). Between 1985 and 2017, 1,173 SRs were published, and in the last 20 years, 10, 35,
Hariprasad Esam   +9 more
doaj   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy